劉建廷 主治醫師
長庚大學醫學系畢業
1.高雄長庚醫院 實習醫師
2.林口長庚醫院 內科部住院醫師
3. 高雄長庚醫院 內科部住院醫師
4.高雄長庚醫院 血液腫瘤科住院醫師
高雄長庚醫院 血液腫瘤科主治醫師
乳癌、肺癌、大腸直腸癌
1.內科專科醫師
2.中華民國腫瘤內科專科醫師
 
1. Chien-Ting Liu, Tai-Jan Chiu, Chi-Yen Chien, Fu-Ming Fang*. Impact of comorbidity on survival for locally advanced head and neck cancer patients treated by radiotherapy or radiotherapy plus chemotherapy. Chang Gung Med Journal, 2010 May, 33(3), 283-91. (NON SCI)

2.Yu-Li Su , Chien-Ting Liu , Tai-Jan Chiu , Shan-Hsuan Li, Tai-Lin Huang , Yen-Yang Chen1 , Yen Tang , Kun-Ming Rau, Cheng-Hua Huang *,Metastatic Mucinous Colorectal Cancer: An Important Subtype of Colorectal Cancer with Poor Response to Chemotherapy and Overall Metastatic Mucinous Colorectal Cancer: An Important Subtype of Colorectal Cancer with Poor Response to Chemotherapy and Overall Survival Metastatic Mucinous Colorectal Cancer: An Important Subtype of Colorectal Cancer with Poor Response to Chemotherapy and Overall Survival. Journal of Cancer Research Practice,2010;26:221-230 (NON SCI)

3. Yen-Hao Chen , Hung-I Lu , Cheng-Hua Huang , Kun-Ming Rau1 , Yi-Chun Chiu, You-Ming Wang, Yen-Yang Chen, Chien-Ting Liu, Shau-Hsuan Li * Trimodality Treatment for Locally Advanced, Resectable Esophageal Squamous Cell Carcinoma Journal of Cancer Research Practice, 2011;27:200-210 (NON SCI)

4. Tien-Hsing Chen, Hung-Ta Wo, Chien-Chia Wu, Jian-Liang Wang, Chun-Chieh Wang, I-Chang Hsieh, Cheng-Yi Kuo, Chien Ting Liu. Exendin-4 attenuates lipopolysaccharides induced inflammatory response but does not protect H9c2 cells from apoptosis. Immunopharmacol Immunotoxicol, 2012 June, 34(3), 484-90. (SCI IF: 1.829)

5. Yen-Hao Chen, Shau-Hsuan Li*, Yi-Chun Chiu, Hung-I Lu, Cheng-Hua Huang, Kun-Ming Rau, Chien-Ting Liu. Comparative study of esophageal stent and feeding gastrostomy/jejunostomy for tracheoesophageal fistula caused by esophageal squamous cell carcinoma. PLoS One, 2012;7:42766. (SCI IF: 4.092 Multidisciplinary Sciences 11/61)

6. Kun-Ming Rau, Chao-Cheng Huang, Tai-Jan Chiu, Yen-Yang Chen, Chien-Chang Lu, Chien-Ting Liu, Sung-Nan Pei, Yu-Ching Wei*. Neovascularization evaluated by CD105 correlates well with prognostic factors in breast cancers. Experimental and Therapeutic Medicine. 2012;4:231-236 (SCI ; IF=1.280 MEDICINE, RESEARCH & EXPERIMENTAL 95/124)

7. Shau-Hsuan Li, Yung-Cheng Huang, Wan-Ting Huang, Wei-Che Lin, Chien-Ting Liu, Wan-Yu Tien, Hung-I Lu*. Is there a role of whole-body bone scan in patients with esophageal squamous cell carcinoma.BMC Cancer, 2012 (12), 328. (SCI IF: 4.1 ONCOLOGY 85/213)

8. Han-Chi Tseng, Chien-Ting Liu, Ji-Chen Ho, Shang-Hon Lin*. Necrolytic migratory
erythema and glucagonoma rising from pancreatic cancer. Pancreatology. 2013 13(4), 455-457. (SCI IF: 2.043 GASTROENTEROLOGY & HEPATOLOGY 44/79)

9. Ming-Chun Ma,Yen-Yang Chen,Shau-Hsuan Li,Yu-Fan Cheng,Chih-Chi Wang,Tai-Jan Chiu,Sung-Nan Pei,Chien-Ting Liu,Tai-Lin Huang,Chen-Hua Huang,Yu-Li Su,Yen-Hao Chen,Sheng-Nan Lu,Kun-Ming Rau*,Intra-Arterial Chemotherapy with Doxorubicin and Cisplatin Is Effective for Advanced Hepatocellular Cell Carcinoma. The Scientific World Journal,2014;2014:160138 (NON SCI)

10. Chien-Ting Liu, Yi-Chun Chiu, Yen-Yang Chen*,Multiple Endocrine Neoplasia Type 1 With Gastric Neuroendocrine Tumor Presented With Gastric Polyposis. Clinical Gastroenterology and Hepatology. 2015 May;13(5):e45 (SCI ; IF=7.680 ; GASTROENTEROLOGY & HEPATOLOGY 7/79)

11. Shih-Chun Chang, Chien-Hung Liao, Shang-Yu Wang, Chun-Yi Tsai, Kun-Chun Chiang, Chi-Tung Cheng, Ta-Sen Yeh, Yen-Yang Chen, Ming-Chun Ma, Chien-Ting Liu, Chun-Nan Yeh*.Feasibility and Timing of Cytoreduction Surgery in Advanced (Metastatic or Recurrent) Gastrointestinal Stromal Tumors During the Era of Imatinib. Medicine,2015;94:1-6 (SCI ; IF=2.133 MEDICINE,GENERAL&INTERNAL 40/153)

12. Chi-Tung Cheng, Yin-Yi Chu, Chun-Nan Yeh*,Shih-Chiang Huang,Ming Huang Chen,Shang-Yu Wang,Chun-Yi Tsai,Kun-Chun Chiang, Yen-Yang Chen,Ming-Chun Ma,Chien-Ting Liu,Tsung-Wen Chen, Ta-Sen Yeh.Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma. Onco Targets Therapy. 2015; 8: 1899–1907. (SCI ; IF=2.272 BIOTECHNOLOGY&APPLIED MICROBIOLOGY 70/161)

13. Chou, Wen-Chi;Yeh, Kun-Yun; Peng, Meng-Ting;Chen, Jen-Shi ; Wang, Hung-Ming; Lin, Yung-Chang; Liu, Chien-Ting; Chang, Pei-Hung; Wang, Cheng-Hsu;Chen, Ping-Tsung; Hung, Yu-Shin;Lu Chang-Hsien* ,Development and Validation of a Prognostic Score to Predict Survival in Adult Patients With Solid Tumors and Bone Marrow Metastases.Medicine.2015;94:e966 (SCI ; IF=2.133 MEDICINE,GENERAL&INTERNAL 40/153)

14. Wen-Chi Chou*, Pei-Hung Chang, Chang-Hsien Lu, Keng-Hao Liu, Yu-Shin Hung, Chia-Yen Hung, Chien-Ting Liu, Kun-Yun Yeh, Yung-Chang Lin, Ta-Sen Yeh. Effect of Comorbidity on Postoperative Survival Outcomes in Patients with Solid Cancers: A 6-Year Multicenter Study in Taiwan. J Cancer 2016; 7(7):854-861. doi:10.7150/jca.14777. (SCI IF: 3.609 ONCOLOGY 73/213)

15. Chien-Ting Liu, Ming-Huang Chen, Jen-Shi Chen, Li-Tzong Chen, Yan-Shen Shan, Chang-Hsien Lu, Yu-Li Su, Fan-Chen Ku, Wen-Chi Chou*,Yen-Yang Chen. The efficacy and safety of everolimus for the treatment of progressive gastroenteropancreatic neuroendocrine tumors: A multi-institution observational study in Taiwan. Asia-Pacific Journal of Clinical Oncology. 2016 doi: 10.1111/ajco.12571. (SCI IF: 1.722 ONCOLOGY 169/213)

16. Chang-Hsien Lu, Chien-Ting Liu, Pei-Hung Chang, Kun-Yun Yeh, Chia-Yen Hung, Shau-Hsuan Li, Yung-Chang Lin, Ta-Sen Yeh , Yung-Shin Hung , Wen-Chi Chou*. Validation and Comparison of the 7th Edition of the American Joint Committee on Cancer Staging System and Other Prognostic Models to Predict Relapse-Free Survival in Asian Patients with Parotid Cancer. J Cancer. 2016 Aug 15;7(13):1833-1841. (SCI IF: 3.609 ONCOLOGY 73/213)

17. Meng-Ting Peng, Chien-Ting Liu, Yu-Shin Hung, Chen-Yi Kao, Pei-Hung Chang, Kun-Yun Yeh, Hung-Ming Wang, Yung-Chang Lin, Wen-Chi Chou*. Sequential Assessments of the Eastern
Cooperative Oncology Group Performance Scale Enhance Prognostic Value in Patients With Terminally Ill Cancer Receiving Palliative Care. American Journal of Hospice & Palliative Medicine, 2016; 33(5):471-6 (SCI ; IF=1.296 ; Health Care Sciences & Services 65/88)